Lisinopril and Hydrochlorothiazide
NDC 42708-150, Lisinopril and Hydrochlorothiazide, tablet, from QPharma, Inc..
- Product NDC
- 42708-150
- Status
- Listed
- Labeler
- QPharma, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077912
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42708-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROCHLOROTHIAZIDE12.5 mg/1
- LISINOPRIL10 mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42708-150-30 | 42708015030 | 30 TABLET in 1 BOTTLE, PLASTIC (42708-150-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c80b2164-3795-6668-e053-2a95a90a4d45
Use it
Look up 42708-150 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42708-150 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42708-150. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.